AACC Annual Scientific Meeting Focuses On The Latest Research on Cannabis Use and Testing

PENNSYLVANIA: At the 68th AACC Annual Scientific Meeting & Clinical Lab Expo—the premier global conference and exhibit for laboratory medicine—visionaries in the field will illuminate the pioneering research and technology paving the way for better clinical testing and patient care. From July 31–August 4 in Philadelphia, the meeting will feature more than 200 talks on a broad range of timely healthcare topics. Highlights of these include plenaries that explore the latest research on cannabis use.

As legal recreational and medical marijuana use gains traction, it is critical that law enforcement have a way to test for whether someone is driving under the influence. However, recent research has revealed that determining whether a driver is impaired by marijuana is much more complicated than testing for blood alcohol content. In a plenary session, Marilyn A. Huestis, PhD, of the National Institute on Drug Abuse, will present the latest findings on the impact of cannabis use on driving and overall health, as well as the newest developments in testing for cannabinoids in blood and saliva.

Researchers from Calgary Laboratory Services in Canada will also present a study on a new urine test to detect cannabis and its metabolites that is accurate and cost-effective.